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Abstract
Background: Good and reliable atrial sensing is a fundamental part of atrioventricular (AV) 
synchrony in dual chamber pacemakers. Due to the floating nature of atrial sensing electrode in 
single   pass   dual   chamber   pacemakers   (VDD)   compared   with   two-lead   dual   chamber 
pacemakers (DDD), they are more prone to atrial under-sensing and the resulting loss of AV 
synchrony. We hypothesized that there is a relation between the chronicity of AV block and the 
amplitude of intracardiac atrial signal amplitudes (IASA).                                    
Methods:  Detailed   demographic,   electrocardiographic   and   echocardiographic   data   were 
recorded in 34 consecutive patients with congenital and acquired complete heart block (CHB). 
The intracardiac atrial signal amplitudes (IASA) were recorded at implantation time, 48 hours 
and 2 months post-implantation and compared between the two groups of patients.       
Results: The mean age of the study group was 38.73±12.53 years (congenital: 30.08±11.07, 
acquired: 47.38±6.5). There were no important differences in left atrial or ventricular sizes and 
in P-wave amplitude in lead II, but the IASA was significantly higher in the congenital group at 
implantation time (5.21±1.86 vs. 3.38±0.84 mV, P<0.001) and during the follow-up.         
Conclusion: The intracardiac atrial signal amplitudes were higher in congenital CHB compared 
with the acquired CHB. Chronicity (and may be the congenital type) of CHB may be an 
affecting factor in case selection for VDD pacemaker implantation.                          
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Introduction
With maintenance of AV synchrony in dual chamber pacemakers (compared to ventricular 
pacing only), patients may experience better hemodynamics and improved exercise tolerance. 
Furthermore, they may have a lower chance for developing atrial fibrillation (AF), heart failure 
and cerebral embolism in the future [1]. One of the main factors in maintenance of AV 
synchrony   is   good   atrial   sensing.                                                                      
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It's been more than three decades since single pass VDD pacemakers were introduced [2]. 
Despite their suggested advantages  such as lower costs, less implantation times, fewer 
complications and also lower potential for development of AF, they are still underutilized. This 
underutilization is attributed to the fear of later on development of sinus node dysfunction or 
atrial undersensing. [3-6]                                                                                         
Hitherto, the effects of factors such as breathing, body position and exercise in atrial 
undersensing have been discussed in various investigations [7-10]. In general, there is a 
tendency towards decreasing atrial signal amplitude during the first several days to weeks after 
lead implantation due to inflammatory response and edema at the electrode tissue interface [11]. 
Moreover, a remarkable difference has been reported between signal amplitude measured by an 
analyzer at the time of implantation, and the one measured during the device interrogation, with 
the signal amplitude being lower in the latter one. [6]. Therefore, it would be logical to assume 
that the more the signal amplitude at the time of implantation, the less the possibility of later 
development of undersensing.                                                                                               
In order to overcome the latter problem, many suggestions have been made such as using active 
autosensing algorithms, right sided implantation, and programming to the highest atrial 
sensitivity. Nevertheless intermittent atrial undersensing still remains as a problem [12-14].        
Burri et al. discovered that there is a direct correlation between the maximal surface P-wave 
amplitude and intra atrial signal amplitude (IASA) measured with a free-floating atrial dipole in 
VDD pacemakers. As well, Wiegand et al. and Brandt et al. have separately suggested the 
existence of a reverse correlation between the age and IASA in VDD and DDD pacemakers 
respectively   [4,   15-17].                                                                                  
There are no data about the relation between IASA and the chronicity of AVB so far. In this 
small-scale study we tried to compare patients with congenital and acquired AV block to test the 
hypothesis that there is a correlation between the duration of AV block and the IASA.
Patients   and   Methods                                                                        
We analyzed the data from 17 patients with congenital CHB (age>18 years) and 17 patients 
with acquired CHB (age<60 years) who received two-lead DDD pacemakers at a referral 
hospital   between   September   2005   and   December   2009.   The   indication   for   pacemaker 
implantation was symptomatic CHB. All patients with a history of open heart surgery were 
excluded to avoid the need for active fixation atrial lead. Written informed consents were 
obtained from all patients and the study was approved by local Ethics committee, and. The 
mean age at implantation was 38.73±12.53 years, and 62% of the patients were women (82% in 
congenital group versus 42% in acquired group). In the acquired group the underlying diseases 
were   hypertension   (30%),   ischemic   heart   disease   (23%),   and   myocarditis   (7.7%).  
The pacing system in both groups included: Medtronic Kappa DR 901 generators (Minneapolis, 
MN, USA), Medtronic Capsure sense 4574-53passive fixation atrial leads, and Medtronic 
Capsure fix 4076-58 active fixation ventricular leads.                                                    
Implantation   Technique                                                                                    
Devices were implanted in electrophysiology laboratory using standard implantation techniques 
by a qualified electrophysiologist. All the leads were implanted through left subclavian vein 
using 7 French peel-away sheaths. The active fixation ventricular leads were implanted in right 
ventricular outflow tract (RVOT) or high right ventricular septum. All passive fixation atrial 
leads were placed in right atrial (RA) appendage. Atrial and ventricular sensing and pacing 
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thresholds and lead impedances were measured by pacing system analyzer (Medtronic Inc., 
Model: 2090EN). The acceptable atrial pacing and sensing threshold measured by the analyzer 
were <1.0V and ≥1.5 mV, respectively. After the leads were secured in the pocket, they were 
anchored to DDD pulse generator.                                                                                           
Follow   Up                                                                                        
Atrial signal amplitudes were measured in supine position at predischarge and two months after 
implantation with the same programmer (Medtronic Inc. Model: 2090EN).                   
Definitions
Congenital CHB was diagnosed by reviewing the previous surface electrocardiograms and 
medical files of the patients in the absence of new events (by history and physical examination).
Analysis  of Data                                                                                               
Continuous variables are displayed as mean ±SD and qualitative variables as numbers. Student 
t-test, Mann-Whitney U-test, and chi-square (Fisher exact) test were used for univariate 
comparison of parameters. A P-value of ≤ 0.05 was considered statistically significant. GLM 
was used for age and sex adjustment.                                                                                 
Results
34 patients having symptomatic CHB (17 patients with congenital and 17 patients with acquired 
CHB) were entered into our study. The clinical and paraclinical characteristics of the patients 
are presented in Table1. Surprisingly, more than 80% of the patients in the congenital group 
were women (p=0.015). The patients in the congenital group were younger than the acquired 
group (30.08±11.07 vs. 47.38±6.50 years, P<0.001).                                                                     
There were no significant differences in body mass index, and left atrial (LA) or right 
ventricular (RV) sizes in echocardiography. Five patients (38.5%) in the acquired group had RV 
dysfunction. Low left ventricular (LV) ejection fraction was more common in the acquired 
group (45.77% ±5.34 vs. 55.38% ±11.63, P=0.015). The right atrial (RA) size was higher in the 
acquired group (3.60 cm ±0.5 vs. 3.22 cm ±o.28, P=0.023). P-wave duration in lead II (2.37mm 
±0.36) and amplitude in lead V1 (1.54 mV ±0.43) were significantly higher in the congenital 
group (p=0.006, P=0.034, respectively). IASA levels were significantly higher in the congenital 
group at implantation time (5.21±1.86 vs. 3.38±0.84 mm, P<0.001) and remained higher during 
the follow up. (Table 1) (Figure 1).
Discussion
The results of the present study indicate higher IASA levels in patients with congenital CHB. 
Studying the fetuses with congenital CHB, Li et al. concluded that these fetuses have surface P 
waves with higher amplitude and longer duration. He suggested that the hypertrophy of the atrial 
myocytes, as a compensatory mechanism in response to low heart rates in these fetuses, was the 
responsible for these findings [18]. In heart blocks with the ensuing AV dyssynchrony (AVD), 
atria could undergo hypertrophic changes. Considering the fact that in patients with congenital 
CHB, AVD usually lasts longer than in patients with acquired CHB; more hypertrophy would be 
expected in the former cases. In our study too, the amplitude and duration of surface P waves 
were   longer   in   patients   with   congenital   CHB   although   this   difference   was   statistically 
considerable  only in terms of duration.                                                                   
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Table:1 Clinical characteristics of subjects according to group
Data are expressed in mean ± SD
P-value: obtained from t-test.  Significant level P-value≤0.05
* P-value: obtained from Mann-Whitney (because of non-normality) 
ξ  P-value: obtained from univariate analyze (adjusted by age and sex)
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Figure 1: Comparison of IASA at implantation time and during follow up in both group.
The cause of the reverse correlation between age and IASA level were suggested to lay in the 
electrophysiologic changes of atrial cells due to the increasing age [17]. Although in our study we 
tried to choose two groups of patients with the least age differences, this difference was still 
statistically significant. However, after adjusting for age, the IASA differences between the two 
groups persisted. As patients presenting with symptomatic acquired CHB can be assumed to have 
a recent onset of disease, the chronicity of development of CHB may be suggested to account for 
the differences in IASA levels in the two groups of patients.                                     
Structural heart diseases are less common in younger patients and the sizes of the atria are 
smaller. These factors may also be the reason for higher IASA levels in younger patients. In this 
study, the right atrial sizes in the acquired group were larger than that of the congenital ones 
(P=0.023) but it was not found to be significant once analyzed by Pearson correlation test.     
Osadchii  et al. explained how myocardial cell hypertrophy occurs much easier in response to 
adrenergic over-activation [19]. The reason may be the longer contact of the congenital CHB 
group with circulatory catecholamines that facilitate atrial hypertrophy in these patients compared 
with the  acquired  group.                                                                                       
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Limitations
This study had its own limitations. This study failed to measure circulatory catecholamine levels 
and compares them in two groups. It might have been helpful if we performed trans-esophageal 
echocardiography (TEE) to measure the thickness of the atrial walls, and the amount of their 
hypertrophy. Our small sample size would not allow for defining age quartiles in the patients with 
congenital CHB. This would allow for further investigation of the role of chronicity on IASA 
levels. A larger study would be more revealing.                                                             
Conclusion
This study suggests that patients suffering from congenital CHB have higher IASA levels 
compared with the acquired CHB patients. The chronicity of CHB may be the primary factor in 
determining  the  IASA   levels.  These  patients  may  be  better   candidates   to  receive   VDD 
pacemakers and less prone to the development of atrial undersensing in the future.           
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